News and Announcements
Hikma engages shareholders over buyback waiver
By Josh White
Date: Thursday 24 Oct 2024
(Sharecast News) - Hikma Pharmaceuticals updated the market over the significant opposition to a resolution at its annual general meeting on Thursday.
The FTSE 100 company said the resolution, known as the rule 9 waiver or buyback waiver, faced over 20% opposition from shareholders during the meeting on 25 April.
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
Article Archive
You are here: news
